# Prostate Cancer Burden and Heterogeneity Evaluation Towards Liquid Biopsy: a Correlation Study to 18FDCFPyL PET and Patients Outcome

> **NCT06917781** · NA · RECRUITING · sponsor: **Institut Claudius Regaud** · enrollment: 80 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **OTHER:** Patients with 18F-PET-PSMA indication

## Key facts

- **NCT ID:** NCT06917781
- **Lead sponsor:** Institut Claudius Regaud
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-28
- **Primary completion:** 2027-10
- **Final completion:** 2028-10
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06917781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06917781, "Prostate Cancer Burden and Heterogeneity Evaluation Towards Liquid Biopsy: a Correlation Study to 18FDCFPyL PET and Patients Outcome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06917781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*